Xtant Medical Holdings (XTNT) Gross Profit (2010 - 2025)

Xtant Medical Holdings (XTNT) has reported Gross Profit for 16 consecutive years, with $17.8 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Gross Profit rose 10.8% year-over-year to $17.8 million in Q4 2025; TTM through Dec 2025 was $84.3 million, a 23.54% increase from a year earlier, with the FY2025 full-year figure at $84.3 million, up 23.54% from the prior year.
• Gross Profit was $17.8 million for Q4 2025 at Xtant Medical Holdings, down from $22.0 million in the prior quarter.
• Over five years, Gross Profit peaked at $24.3 million in Q2 2025 and troughed at $7.2 million in Q3 2021.
• A 5-year average of $13.6 million and a median of $13.9 million in 2023 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit slipped 22.24% in 2021 and surged 106.32% in 2023, its largest moves.
• Over 5 years, Gross Profit stood at $7.7 million in 2021, then grew by 7.94% to $8.3 million in 2022, then surged by 106.32% to $17.1 million in 2023, then slipped by 6.49% to $16.0 million in 2024, then advanced by 10.8% to $17.8 million in 2025.
• The last three Gross Profit figures came in at $17.8 million (Q4 2025), $22.0 million (Q3 2025), and $24.3 million (Q2 2025), per Business Quant data.